E. Lynne Kelley
Nessuna posizione attualmente
Profilo
E.
Lynne Kelley is currently the Chief Executive & Medical Officer at Signalexis, Inc. Previously, she held positions as Medical Director at Kimberly-Clark Corp.
and Boston Scientific Corp., Assistant Professor at Yale University, and Vice President-Medical Affairs at Becton, Dickinson & Co. She also served as Chief Medical Officer at Histogenics Corp., Senseonics Holdings, Inc., and X4 Pharmaceuticals, Inc. Kelley received her undergraduate degree from Boston University and her doctorate from Dartmouth Medical School.
Posizioni attive di E. Lynne Kelley
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di E. Lynne Kelley
| Società | Posizione | Fine |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 03/04/2020 |
| OCUGEN, INC. | Direttore Tecnico/Scientifico/R&S | 23/01/2019 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/01/2016 |
| KIMBERLY-CLARK CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/12/2010 |
| BOSTON SCIENTIFIC CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/01/2007 |
Formazione di E. Lynne Kelley
| Boston University | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| KIMBERLY-CLARK CORPORATION | Consumer Non-Durables |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- E. Lynne Kelley
